110 related articles for article (PubMed ID: 9620888)
1. Blue toe syndrome after initiation of low-dose oral anticoagulation.
Rauh G; Spengel FA
Eur J Med Res; 1998 Jun; 3(6):278-80. PubMed ID: 9620888
[TBL] [Abstract][Full Text] [Related]
2. Atheromatous embolization precipitated by oral anticoagulants.
Bols A; Nevelsteen A; Verhaeghe R
Int Angiol; 1994 Sep; 13(3):271-4. PubMed ID: 7822905
[TBL] [Abstract][Full Text] [Related]
3. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux.
Rindone JP; Mellen CK; Eliason JD
Am J Ther; 2011 Nov; 18(6):e277-9. PubMed ID: 20535004
[TBL] [Abstract][Full Text] [Related]
4. [Blue toe syndrome--a rare but possible complication of anticoagulant therapy].
Varis J; Kuusniemi K; Heiro M; Järveläinen H
Duodecim; 2011; 127(11):1154-7. PubMed ID: 21755807
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
[TBL] [Abstract][Full Text] [Related]
6. [Blue toe syndrome; a sign of end-arterial occlusion].
Nijhof IS; Majoie IM; Dijkhorst-Oei LT; Bousema MT
Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1261-7. PubMed ID: 17624153
[TBL] [Abstract][Full Text] [Related]
7. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
8. Oral anticoagulant therapy: a precipitating factor in the pathogenesis of cholesterol embolization?
Nevelsteen A; Kutten M; Lacroix H; Suy R
Acta Chir Belg; 1992; 92(1):33-6. PubMed ID: 1553847
[TBL] [Abstract][Full Text] [Related]
9. [Multiple cholesterol emboli syndrome: beneficial effects of early heparin therapy. A case report].
Lekeufack JB; Delrée P; Goergen M; Bouazza F; Salmon K; Raynal P; Azagra JS; Sellitti E; Dehon P
Ann Cardiol Angeiol (Paris); 1999 Oct; 48(8):575-8. PubMed ID: 12555463
[TBL] [Abstract][Full Text] [Related]
10. [Blue toe syndrome after coronary artery bypass grafting].
Fukushima Y; Yoshioka M; Niina K; Onitsuka T
Kyobu Geka; 2001 Jun; 54(6):489-92. PubMed ID: 11424500
[TBL] [Abstract][Full Text] [Related]
11. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol embolization following coronary angioplasty.
Fuks DF; Griguoli RE; Borracci RA; Sala C
Rev Port Cardiol; 1992 Dec; 11(12):1089-91. PubMed ID: 1290653
[TBL] [Abstract][Full Text] [Related]
13. Making the diagnosis when the patient has 'blue toes'.
Blackshear JL; Oldenburg WA; Cohen MD
Geriatrics; 1994 Dec; 49(12):37-9, 43-5. PubMed ID: 7982584
[TBL] [Abstract][Full Text] [Related]
14. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
Fernández MA; Andreu R; Fortea JM; Aznar J
Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514
[No Abstract] [Full Text] [Related]
15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
16. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
Reicke B; Masuhr F; Weih M
Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
[TBL] [Abstract][Full Text] [Related]
17. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
18. The purple toe syndrome in female with Factor V Leiden mutation successfully treated with enoxaparin.
Dulíček P; Bártová J; Beránek M; Malý J; Pecka M
Clin Appl Thromb Hemost; 2013; 19(1):100-2. PubMed ID: 22531482
[TBL] [Abstract][Full Text] [Related]
19. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
[TBL] [Abstract][Full Text] [Related]
20. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
Gohlke-Bärwolf C
Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
